JOINT PAIN INJECTIONS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

The risk of side effects of joint pain injections is significantly restraining the growth of the global joint pain injections market. Joint pain injections involve administering corticosteroids and other drugs directly into the joints to reduce inflammation and pain. While these injections provide effective short-term relief, they are associated with several potential side effects. Common side effects include increased pain, swelling or bruising at the injection site. In some rare cases, injections can also cause tendon or ligament damage if the drug leaks into surrounding tissues. This is a major concern for patients and doctors alike.

Market Opportunities – Increasing Adoption of Inorganic Growth Strategies

Increasing adoption of inorganic growth strategies such as agreements among key market players is expected to offer lucrative market growth opportunities. For instance, in December 2023, Bioventus Inc., a healthcare company, announced a contract with Aetna Inc., a health insurance company, for Aetna Medicare Advantage plan. Under the terms of agreement, Aetna Medicare Advantage plan members will have access to Durolane to treat knee osteoarthritis (OA) pain. Durolane is a single-injection hyaluronic acid (HA)-based joint-fluid treatment for patients.